A new NYU Langone Health study found breast cancer patients treated with chemo did not have an increased risk for COVID infection compared to patients who had other therapies.READ MORE: COVID-19: Experts Say Delta Variant Spreads Quickly And Is Dominant Strain In Under-Vaccinated Areas
The study followed more than 3,000 breast cancer patients treated at the height of the pandemic.READ MORE: New York's COVID State Of Emergency Set To Expire Thursday
“We also found that patients who contracted COVID-19 who had previously received chemotherapy did not have a higher mortality rate,” said Dr. Douglas Marks, a medical oncologist with NYU Langone Health’s Perlmutter Cancer Center.
Older and overweight patients, however, were found to have a higher risk of dying from COVID.MORE NEWS: Every NYC Resident Now Eligible For In-Home COVID Vaccine, De Blasio Says
Researchers say this study is believed to be the first to look at whether breast cancer therapies can affect COVID-19 infection and death risk.